Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Net Income: 2018-2024

Historic Net Income for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$80.9 million.

  • Arcturus Therapeutics Holdings' Net Income fell 94.81% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 6.57%. This contributed to the annual value of -$80.9 million for FY2024, which is 172.30% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Net Income stood at -$80.9 million for FY2024, which was down 172.30% from -$29.7 million recorded in FY2023.
  • Arcturus Therapeutics Holdings' Net Income's 5-year high stood at $9.3 million during FY2022, with a 5-year trough of -$203.7 million in FY2021.
  • Its 3-year average for Net Income is -$33.8 million, with a median of -$29.7 million in 2023.
  • In the last 5 years, Arcturus Therapeutics Holdings' Net Income spiked by 104.59% in 2022 and then plummeted by 417.95% in 2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Net Income (Yearly) stood at -$71.5 million in 2020, then plummeted by 184.76% to -$203.7 million in 2021, then spiked by 104.59% to $9.3 million in 2022, then tumbled by 417.95% to -$29.7 million in 2023, then tumbled by 172.30% to -$80.9 million in 2024.